<?xml version="1.0" encoding="UTF-8"?>
<ref id="B285" class="ref">
 <mixed-citation publication-type="journal" class="mixed-citation">
  <person-group person-group-type="author" class="person-group">
   <name class="name">
    <surname class="surname">Tsuneki</surname>
    <given-names class="given-names">H.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Ma</surname>
    <given-names class="given-names">E. L.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Kobayashi</surname>
    <given-names class="given-names">S.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Sekizaki</surname>
    <given-names class="given-names">N.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Maekawa</surname>
    <given-names class="given-names">K.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Sasaoka</surname>
    <given-names class="given-names">T.</given-names>
   </name>
   <etal class="etal"/>
  </person-group> (
  <year class="year">2005</year>). 
  <article-title class="article-title">Antiangiogenic activity of β-eudesmol 
   <italic class="italic">in vitro</italic> and 
   <italic class="italic">in vivo</italic>.
  </article-title>
  <source class="source">
   <italic class="italic">Eur. J. Pharmocol.</italic>
  </source>
  <volume class="volume">512</volume>
  <fpage class="fpage">105</fpage>–
  <lpage class="lpage">115</lpage>.
 </mixed-citation>
</ref>
